Fatigue, depression, and physical activity in patients with malignant hyperthermia: a cross-sectional observational study
Braz. J. Anesth. (Impr.); 73 (2), 2023
Abstract Background Malignant Hyperthermia (MH) is a pharmacogenetic disorder triggered by halogenated anesthesia agents/succinylcholine and characterized by hypermetabolism crisis during anesthesia, but also by day-to-day symptoms, such as exercise intolerance, that may alert the health professional. ...